Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.
about
3p22.1p21.31 microdeletion identifies CCK as Asperger syndrome candidate gene and shows the way for therapeutic strategies in chromosome imbalances.Predicting Autism Spectrum Disorder Using Blood-based Gene Expression Signatures and Machine Learning.Lurasidone for the treatment of irritability and anger in autism spectrum disorders.
P2860
Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.
@ast
Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.
@en
type
label
Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.
@ast
Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.
@en
prefLabel
Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.
@ast
Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.
@en
P2093
P2860
P356
P1476
Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder
@en
P2093
Ah Rah Lee
Chan Young Shin
Chanmin Park
Geon Ho Bahn
Hee Jeong Yoo
Soo Hyun Oh
Yeon Jung Lee
P2860
P356
10.9758/CPN.2014.12.1.19
P577
2014-04-24T00:00:00Z